Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group.- KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl, 2013, 3, 1-150.
Maillard N, Delanaye P, Mariat C.- Exploration de la fonction glomérulaire rénale: estimation du débit de filtration glomérulaire. Nephrol Ther, 2015, 11, 54-67.
Vidal-Petiot E & Flamant M.- Mesure et estimation du débit de filtration glomérulaire. Nephrol Ther, 2017, 13, 560-568.
Newman D, Pugia M, Lott J, et al.- Urinary protein and albumin excretion corrected by specific gravity. Clin Chim Acta, 2001, 294, 139-155.
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group.-KDIGO clinical practice guideline for glomerulo-nephritis. Kidney Int Suppl, 2012, 2, 139-274.
Johnson DW.- Global proteinuria guidelines: are we nearly there yet? Clin Biochem Rev, 2011, 32, 89-95.
National Clinical Guideline Centre (UK) (2014).-Chronic Kidney Disease (Partial Update): Early Identification and Management of Chronic Kidney Disease in Adults in Primary and Secondary Care. En Ligne: https://www.nice.org.uk/Guidance/ cg73, consulté le 8 mai 2018.
Haute Autorité de Santé (France) (2011).-Evaluation du rapport albuminurie / créatininurie dans le diagnostic de la maladie rénale chronique chez l'adulte. En Ligne:, https://www.has-sante.fr/portail/jcms/c_1169049/fr/evaluation-du-rapport-albuminurie/creatininu-rie-dans-le-diagnostic-de-la-maladie-renale-chronique-chez-l-adulte-rapport-d-evaluation, consulté le 8 mai 2018.
Lamb EJ, MacKenzie F, & Stevens PE.- How should proteinuria be detected and measured? Ann Clin Biochem, 2009, 46, 205-217.
Xin G, Wang M, Jiao L li, et al.- Protein-to-creatinine ratio in spot urine samples as a predictor of quantitation of proteinuria. Clin Chim Acta, 2004, 350, 35-39.
Price CP, Newall RG, Boyd JC, et al.- Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review. Clin Chem, 2005, 51, 1577-1586.
Rumley A. - Urine dipstick testing: Comparison of results obtained by visual reading and with the Bayer CLINITEK 50. Ann Clin Biochem, 2000, 37, 220-221.
Burtis, A C, Edward R, & Bruns, E D.- Tietz Textbook of Fundamentals of Clinical Chemistry. 6th Edition. Saunders Elsevier, USA, 2008, 308, 641, 643-644.
King Strasinger S & Schaub Di Lorenzo M.- Urinalysis and body fluids. 5th Edition. F.A. Davis Company, Philadelphia, 2008, 58-61.
Croal BL, Finlay D, & Davidson E.- Evaluation of the Bayer Multistix PRO 10LS Point-of-Care Urine Test, 2003, 2, 144-148.
National Kidney Foundation.- K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis, 2002, 39, 1-266.
Matsushita K, Coresh J, Sang Y, et al.- Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol, 2015, 3, 514-525.
Anderson S, Rennke HG, & Brenner BM.- Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest, 1986, 77, 1993-2000.
Remuzzi G.- Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet, 1996, 349, 1857-1863.
Xie X, Liu Y, Perkovic V, et al.- Renin-angioten-sin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials. Am J Kidney Dis, 2016, 67, 728-741.
Scheen AJ,Paquot N.- Actualisation 2015 des recommandations américaines et européennes pour le traitement du diabète de type 2. Rev Med Liège, 2015, 70, 122-128.
Scheen AJ, Delanaye P.- Effects of reducing blood pressure on renal outcomes in patients with type 2 diabetes: Focus on SGLT2 inhibitors and EMPA-REG OUTCOME. Diabetes Metab, 2017, 43, 99-109.
